508 results match your criteria Chondromyxoid Fibroma


[Chondromucinous tumors involving craniocerebral slope area: a clinicopathological analysis of eight cases].

Zhonghua Bing Li Xue Za Zhi 2019 Mar;48(3):199-203

Department of Pathology, Henan Provincial People's Hospital, Zhengzhou 450003, China.

To investigate the histological type and clinicopathological characteristics of the craniocerebral slope tumors with chondromucinous features. Retrospective analysis was conducted to analyze chondromucinous tumors in the slope area diagnosed at Henan Provincial People's Hospital from October 2011 to June 2018. Relevant clinical and pathological data were reviewed, and immunohistochemistry was used to investigate the immunophenotype of the tumors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0529-5807.2019.03.006DOI Listing
March 2019
1 Read

Chondromyxoid fibroma of the temporal bone: A case report and review of the literature.

World J Clin Cases 2018 Dec;6(16):1210-1216

Department of Radiology, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China.

Background: Chondromyxoid fibroma (CMF) is a rare benign bone tumour of cartilaginous origin, which usually affects the metaphysis of the long bone. Involvement of the temporal bone is extremely rare. Patients with CMF in the temporal bone can present some neurological deficits due to involvement of surrounding neural structures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12998/wjcc.v6.i16.1210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306630PMC
December 2018
2 Reads

An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.

Genes Chromosomes Cancer 2019 02 24;58(2):88-99. Epub 2018 Dec 24.

Department of Pathology, The Royal National Orthopaedic Hospital, Stanmore, Middlesex, United Kingdom.

The last decade has seen the majority of primary bone tumor subtypes become defined by molecular genetic alteration. Examples include giant cell tumour of bone (H3F3A p.G34W), chondroblastoma (H3F3B p. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/gcc.22699
Publisher Site
http://dx.doi.org/10.1002/gcc.22699DOI Listing
February 2019
8 Reads

Chondromyxoid fibroma with a secondary aneurysmal bone cyst of the distal radius: A case report.

J Orthop Sci 2018 Dec 20. Epub 2018 Dec 20.

Department of Orthopaedic Surgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jos.2018.11.017DOI Listing
December 2018
1 Read

Chondromyxoid Fibroma of the Pelvis: Institutional Case Series With a Focus on Distinctive Features.

Int J Surg Pathol 2018 Dec 23:1066896918820446. Epub 2018 Dec 23.

1 Johns Hopkins University, Baltimore, MD, USA.

Chondromyxoid fibroma (CMF) is a relatively uncommon benign bone tumor of cartilaginous differentiation. The primary pitfall in the histopathologic diagnosis of CMF is confusion with a high-grade chondrosarcoma, owing to the atypical stellate and spindled cells set within a chondromyxoid background. CMF is particularly challenging to diagnose within the pelvis, where clinical suspicion for chondrosarcoma is high and benign lesions may grow to a large size to occupy the pelvic bones. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1066896918820446
Publisher Site
http://dx.doi.org/10.1177/1066896918820446DOI Listing
December 2018
4 Reads

Surface-type chondromyxoid fibroma in an elderly patient: a case report and literature review.

Skeletal Radiol 2019 May 29;48(5):823-830. Epub 2018 Nov 29.

Department of Musculoskeletal Radiology, NYU Langone Health, New York, NY, USA.

Chondromyxoid fibroma (CMF) is a rare benign bone neoplasm that typically occurs in young adults. Juxtacortical or surface-type CMF are rarer still and we present the case of a surface-type CMF in a 78-year-old woman, with only one other case described in a patient of a similar age previously. This patient was an otherwise healthy woman who presented for evaluation of a palpable lump in the anterior proximal tibia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-018-3120-4DOI Listing
May 2019
3 Reads

Huge chondromyxoid fibroma of the right iliac wing with tremendous soft tissue extensions.

BJR Case Rep 2018 21;4(1):20170014. Epub 2017 Oct 21.

Department of Radiology, Benha University, Benha, Egypt.

This report describes a huge chondromyxoid fibroma (CMF) that developed in the right iliac crest and wing. The tumour is rare, perhaps the rarest of all bone tumours, and its occurrence in the iliac crest and wing of a 63-year-old male is extraordinarily uncommon. The patient complained of gradual onset of right groin pain over a period of more than 2 years and low back pain and tender swelling of the right gluteal region over a period of another 1 year. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjrcr.20170014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159151PMC
October 2017
16 Reads

Histone H3K36M mutation and trimethylation patterns in chondroblastoma.

Histopathology 2019 Jan 4;74(2):291-299. Epub 2018 Nov 4.

Department of Pathology, Memorial Sloan Kettering Cancer Center, Great Neck, NY, USA.

Aims: Histones are essential components of chromatin, and mutations in histones lead to alterations in methylation and acetylation, which play an important role in tumorigenesis. Most of the chondroblastomas harbour the H3K36M mutation. With the availability of a mutation-specific antibody, we sought to assess the sensitivity of this antibody and the alterations of histone methylation in a series of chondroblastoma cases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13725DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298805PMC
January 2019
20 Reads

Treatment of cryotherapy and orthotopic transplantation following chondromyxoid fibroma of zygomatic bone: A case report.

Medicine (Baltimore) 2018 Aug;97(31):e11707

Department of Oral, Maxillofacial, Cephalic and Cervical Tumors, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Huangpu District, Shanghai, China.

Introduction: Chondromyxoid fibrotherma (CMF) is a rare benign cartilage tumor that occurs more frequently in young males at the age of 20 to 30. It occurs more frequently on long bones, but rarely involves craniofacial bones.

Case Presentation: This study mainly introduced a 30-year-old male with CMF of zygomatic bone. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000011707DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081066PMC
August 2018
13 Reads

[Effectiveness of unicompartment allografts replacement for bone tumor around the knee].

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2017 08;31(8):908-912

Department of Orthopaedics, General Hospital of Chinese PLA, Beijing, 100853, P.R.China.

Objective: To analyze the effectiveness of unicompartment allografts replacement for reconstructing bone defect after bone tumor resection around knee.

Methods: Between January 2007 and January 2014, a total of 9 patients received unicompartment allografts replacement to treat bone tumor around the knee, including 6 males and 3 females, with an average age of 25.8 years (range, 17-38 years). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7507/1002-1892.201704044DOI Listing
August 2017
4 Reads

A case report on partial scapulectomy with glenoid preservation for Chondromyxoid fibroma of scapula.

J Clin Orthop Trauma 2018 Mar 28;9(Suppl 1):S129-S135. Epub 2017 Dec 28.

Professor, Department of Orthopaedics, Assam Medical College & Hospital, Dibrugarh, Assam, India.

Chondromyxoid fibroma is a benign bone tumour accounting for less than 1% of all primary bone tumours. It usually affects the metaphyseal region of long bones in the first or second decade of life. It rarely occurs in scapula. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcot.2017.12.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883918PMC
March 2018
2 Reads

Fluorescent In Situ Hybridization for TP53 in the Diagnosis of Pediatric Osteogenic Sarcoma.

Am J Surg Pathol 2018 Jun;42(6):744-749

Division of Pathology.

Osteogenic sarcoma (OS) is the most common malignant bone tumor in children and adolescents. Despite advances in molecular genetic characterization of pediatric and adult tumors, the diagnosis of OS still depends almost entirely on light microscopy. The lack of consistent genetic changes in OS has greatly hindered the development of any diagnostic molecular test. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000001054DOI Listing
June 2018
11 Reads

Peering beneath the surface: Juxtacortical tumors of bone (part I).

Clin Imaging 2018 Sep - Oct;51:1-11. Epub 2018 Feb 3.

Department of Radiology, Cleveland Medical Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH, USA.

Juxtacortical or surface tumors of bone are neoplasms arising from or just outside the cortex, and are composed of different histologic types. Although the imaging appearances of these lesions have similarities to their intramedullary counterparts, their location alters their radiographic and MR characteristics, creating difficulties in diagnosis. Meanwhile, several non-neoplastic lesions, such as stress reaction/stress fracture and indolent infectious processes, compound the differential diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2018.01.009DOI Listing
December 2018
36 Reads

Chondromyxoid Fibroma of the Metatarsal Bone: A Diagnosis Using Fine Needle Aspiration Biopsy.

J Cytol 2018 Jan-Mar;35(1):67-68

Department of Orthpaedics, Andaman and Nicobar Islands Institute of Medical Sciences, Port Blair, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/JOC.JOC_48_17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795736PMC
February 2018
3 Reads

Benign Chondromyxoid Fibroma of the Iliac Crest.

J Orthop Sports Phys Ther 2018 02;48(2):122

A 23-year-old woman initiated a running program and after 2 months began experiencing right hip joint pain and sharp pain at the iliac crest. Following evaluation by her primary care physician, she was referred to a physical therapist. Eighteen months later, the patient had developed a bony prominence at the iliac crest that was painful to touch. Read More

View Article

Download full-text PDF

Source
http://www.jospt.org/doi/10.2519/jospt.2018.7551
Publisher Site
http://dx.doi.org/10.2519/jospt.2018.7551DOI Listing
February 2018
8 Reads

Peering beneath the surface: juxtacortical tumors of bone (part II).

Clin Imaging 2018 Jul - Aug;50:113-122. Epub 2018 Jan 11.

Department of Radiology, Cleveland Medical Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH, USA.

Juxtacortical or surface tumors of bone are neoplasms arising from or just outside the cortex, and are composed of different histologic types. Although the imaging appearances of these lesions have similarities to their intramedullary counterparts, their location alters their radiographic and MR characteristics, creating difficulties in diagnosis. Meanwhile, several non-neoplastic lesions, such as stress reaction/stress fracture and indolent infectious processes, compound the differential diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2018.01.005DOI Listing
October 2018
18 Reads

Chondromyxoid Fibroma Arising in Craniofacial Sites: A Clinicopathologic Analysis of 25 Cases.

Am J Surg Pathol 2018 03;42(3):392-400

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Chondromyxoid fibroma (CMF) is a rare benign tumor, usually arising in the metaphysis of long bones in young adults. Occurrence in craniofacial bones presents a particular diagnostic challenge given its unusual location and resemblance to malignant mimics. We describe the clinicopathologic features of 25 cases of craniofacial CMF identified between 1999 and 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000001019DOI Listing
March 2018
8 Reads

Radiological presentation of chondromyxoid fibroma in the sellar region: A CARE-compliant article and literature review.

Medicine (Baltimore) 2017 Dec;96(49):e9049

aDepartment of Neurology, Shengjing Hospital of China Medical University, Shenyang, Liao Ning, ChinabDepartment of Pathology, Duke University Medical Center, Durham, NCcDepartment of Pathology, First Affiliated Hospital of China Medical University and College of Basic Medical Sciences, Shenyang, Liao Ning, China.

Rationale: Chondromyxoid fibroma (CMF) is a rare benign bone neoplasm which often occurs in the lower extremities. Little is known about the radiological and histological presentation of CMF in the sellar region.

Patient Concerns: A 16-year-old Asian male presented to the hospital 12 months ago with bilateral diplopia involving right visual fields, intermittent headaches, and dizziness. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000009049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728922PMC
December 2017
18 Reads

Long-lasting chondromyxoid fibroma of the zygoma: A rare case report and review of literature.

J Educ Health Promot 2017 9;6:78. Epub 2017 Aug 9.

Department of Otolaryngology, Clinical Pathology Division, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Chondromyxoid fibroma (CMF) is a benign tumor which usually occurs in skeletal long bones. Its presence in zygoma is extremely rare. The patient was a 47-year-old female, with chief complaint of painful swelling in the left side of zygoma since 1 month ago after a long-lasting painless swelling for about 15 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/jehp.jehp_33_17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561685PMC
August 2017
11 Reads

An intracortical chondromyxoid fibroma in the diaphysis of the metatarsal.

Skeletal Radiol 2017 Dec 15;46(12):1757-1762. Epub 2017 Aug 15.

Department of Pathology, Korea University Ansan Hospital, Ansan-si, Republic of Korea.

Chondromyxoid fibromas (CMFs) are rare, benign, primary tumors of bones, and occur in the metaphyses of the medullary canals of the long bones. The occurrence of intracortical CMFs is extremely rare. Very few cases of intracortical CMFs located in the long tubular bones have been reported to date. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-017-2743-1DOI Listing
December 2017
5 Reads

Chondromyxoid fibroma of the distal fibula treated by percutaneous radiofrequency ablation.

J Orthop Surg (Hong Kong) 2017 May-Aug;25(2):2309499017720830

4 Department of Orthopedic Surgery, Hadassah-Hebrew University School of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.

Background: Percutaneous radiofrequency ablation (RFA) has been shown to be an effective treatment for soft tissue lesions and also benign bone tumors, especially osteoid osteoma. There are limited data regarding this technique in other bone tumors, specifically larger and more aggressive ones.

Purposes: To describe the use of RFA as a definitive treatment and an alternative to traditional open surgery for the treatment of chondromyxoid fibroma (CMF), a benign but locally aggressive bone tumor. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2309499017720830DOI Listing
March 2018
6 Reads

[Rare location of chondromyxoid fibroma: about a case].

Pan Afr Med J 2017;26:219. Epub 2017 Apr 24.

Service de Chirurgie Orthopédique et de Traumatologie, CHU Ibn Sina, Université Mohammed V Souissi, Rabat, Maroc.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11604/pamj.2017.26.219.12289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491748PMC
February 2018
6 Reads

Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.

Am J Surg Pathol 2017 Oct;41(10):1371-1380

*Institute of Pathology ††Department of Hand & Plastic Surgery, University Hospital, Erlangen **Institute of Pathology ‡‡Department of Orthopedic & Traumatology, Section for Tumor Orthopedics, University Hospital, Bonn, Germany †Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Prague ‡Biomedical Center of the Faculty of Medicine in Pilsen, Pilsen, Czech Republic §Department of Pathology, University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, PA ∥Department of Pathology, National University Health System, Singapore ¶Department of Pathology, 3rd Medical Faculty in Prague, Charles University, Prague, Czech Republic.

Phosphaturic mesenchymal tumor (PMT) is a rare neoplasm of uncertain histogenesis that has been linked to tumor-induced osteomalacia (TIO) since 1959. The neoplastic cells produce increased amount of FGF23 which results in TIO via uncontrolled renal loss of phosphate (phosphaturia), and consequently diminished bone mineralization. To date, ∼300 cases have been reported. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000890DOI Listing
October 2017
27 Reads

Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy.

Semin Nucl Med 2017 07 12;47(4):322-351. Epub 2017 Apr 12.

Department of Radiology and Nuclear Medicine, Deventer Ziekenhuis, Deventer, The Netherlands.

Positron emission tomography with the radiotracer F-fluoro-2-deoxy-d-glucose (FDG) plays an important role in the evaluation of bone pathology. However, FDG is not a cancer-specific agent, and knowledge of the differential diagnosis of benign FDG-avid bone alterations that may resemble malignancy is important for correct patient management, including the avoidance of unnecessary additional invasive tests such as bone biopsy. This review summarizes and illustrates the spectrum of benign bone conditions that may be FDG-avid and mimic malignancy, including osteomyelitis, bone lesions due to benign systemic diseases (Brown tumor, Erdheim-Chester disease, Gaucher disease, gout and other types of arthritis, Langerhans cell histiocytosis, and sarcoidosis), benign primary bone lesions (bone cysts, chondroblastoma, chondromyxoid fibroma, desmoplastic fibroma, enchondroma, giant cell tumor and granuloma, hemangioma, nonossifying fibroma, and osteoid osteoma and osteoblastoma), and a group of miscellaneous benign bone conditions (post bone marrow biopsy or harvest status, bone marrow hyperplasia, fibrous dysplasia, fractures, osteonecrosis, Paget disease of bone, particle disease, and Schmorl nodes). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2017.02.004DOI Listing
July 2017
36 Reads

[Chondromyxoid fibroma of the mandible: a case report].

Hua Xi Kou Qiang Yi Xue Za Zhi 2016 Dec;34(6):654-656

Dept. of Oral and Maxillofacial Surgery, General Hospital of Ningxia Medical University, Yinchuan 750004, China.

Chondromyxoid fibroma (CMF) is a rare benign bone tumor. This tumor mostly affects the long bones of the appendicular skeleton but rarely grows in the craniofacial region. In this article, a case of CMF of the mandible was presented to enhance our understanding of CMF. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7518/hxkq.2016.06.020DOI Listing
December 2016
6 Reads

Chondromyxoid Fibroma of the Skull Base: Our Experience with an Elusive Disease.

J Neurol Surg A Cent Eur Neurosurg 2017 Nov 2;78(6):576-581. Epub 2017 Mar 2.

Rome Army Hospital "Celio," Neurosurgery Division, Sapienza University Rome, Dipartimento Scienze Neurosensoriali, Rome, Italy.

Chondromyxoid fibroma (CMF) is an extremely rare lesion of the skull base. This histologic type typically predilects metaphysis of the long bones. It is locally invasive/infiltrative, and this tendency is more concerning in the skull base, where a radical resection is often technically impossible because of the presence of vital neurovascular structures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0037-1599137DOI Listing
November 2017
11 Reads

Primary Orbital Chondromyxoid Fibroma: A Rare Case.

Ophthalmic Plast Reconstr Surg 2017 May/Jun;33(3S Suppl 1):S114-S116

Departments of *Ophthalmology and †Neurosurgery, Maywood, Illinois, U.S.A.

A 56-year-old male with history of chronic sinusitis was found to have a 3 cm left orbital lesion on CT. Subsequent MRI demonstrated a multilobulated enhancing soft tissue lesion at the superotemporal region of the left orbit. Initial biopsy was reported as a low-grade sarcoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IOP.0000000000000857DOI Listing
September 2017
9 Reads

Exceptional Rare Giant Craniofacial Chondroid Tumor in Adult.

World Neurosurg 2017 Feb 18;98:867.e1-867.e3. Epub 2016 Dec 18.

Department of Neurosurgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China. Electronic address:

We present a rare case of giant soap bubble-shaped cystic lesion in the craniofacial region in an adult female. Histopathologic examination revealed the tumor consisted of 3 components including chondroblastoma, chondromyxoid fibroma, and hemorrhagic aneurysmal bone cyst. The present case is rare in terms of size, location, and histopathologic diagnosis, which is probably the result of underdeveloped health care in the remote place. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2016.12.032DOI Listing
February 2017
11 Reads

Pediatric Chondromyxoid Fibroma-Like Osteosarcoma.

Fetal Pediatr Pathol 2017 Apr 9;36(2):154-161. Epub 2016 Dec 9.

a Department of Pathology , Children's Hospital New Orleans , New Orleans , LA , USA.

Chondromyxoid fibroma-like osteosarcoma (CMF-OS) is a low-grade osteosarcoma, often misdiagnosed on initial biopsy as a benign lesion, with five cases previously described. We report a 13-year-old male with an intramedullary lytic CMF-OS of the right tibial proximal metaphysis with cortical destruction and soft tissue extension. Diagnosis was based on malignant new bone formation, increased mitotic figures, lamellar bone permeation with bony destruction, and correlation with imaging studies. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/15513815.2016.1
Publisher Site
http://dx.doi.org/10.1080/15513815.2016.1259376DOI Listing
April 2017
10 Reads

Chondromyxoid Fibroma: A Rare Case Report and Review of Literature.

Cureus 2016 Sep 23;8(9):e803. Epub 2016 Sep 23.

Orthopaedics, Sumandeep Vidyapeeth, Vadodara, Gujarat.

Chondromyxoid fibroma (CMF) is one of the rarest benign tumors of cartilaginous origin. It accounts for less than 0.5% of bone tumors and less than two percent of benign bone tumors. Read More

View Article

Download full-text PDF

Source
http://www.cureus.com/articles/5287-chondromyxoid-fibroma-a-
Publisher Site
http://dx.doi.org/10.7759/cureus.803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101078PMC
September 2016
10 Reads

Cytodiagnosis of ChondromyxoidFibroma of the Metatarsal Head: A Case Report.

Iran J Pathol 2016 ;11(3):272-275

Dept. of Pathology, JN Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Chondromyxoid fibroma (CMF) is a rare benign cartilaginous tumor with a predilection for the bones of lower extremities and about one fourth of the tumors involve the foot. Radiologically, an eccentric lytic lesion with well-defined margins is seen in the metaphysis of the bone. We hereby, report an 18 yr old young male who presented to Orthopedic Outpatient Department, JN Medical College, Aligarh Muslim University, India diagnosed with giant cell tumor of the third metatarsal bone of right foot on radiography but on fine needle aspiration cytology (FNAC) the diagnosis of CMF was made. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079461PMC
January 2016
3 Reads

Decalcified allograft in repair of lytic lesions of bone: A study to evolve bone bank in developing countries.

Indian J Orthop 2016 Jul-Aug;50(4):427-33

Department of Orthopaedics, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, Uttar Pradesh, India.

Background: The quest for ideal bone graft substitutes still haunts orthopedic researchers. The impetus for this search of newer bone substitutes is provided by mismatch between the demand and supply of autogenous bone grafts. Bone banking facilities such as deep frozen and freeze-dried allografts are not so widely available in most of the developing countries. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0019-5413.185609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964777PMC
August 2016
6 Reads

Chondromyxoid Fibroma of Radius: A Case Report.

J Clin Diagn Res 2016 May 1;10(5):ED01-2. Epub 2016 May 1.

Professor, Department of Pathology, B.L.D.E.U'S Shri B.M. Patil Medical College Hospital and Research Centre , Vijayapur, India .

Chondromyxoid fibroma (CMF) is a rare benign cartilaginous tumour accounting to less than 1% of bone tumours. It is most commonly seen in lower extremity involving tibia. CMF of radius is rare. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7860/JCDR/2016/17967.7728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948408PMC
May 2016
3 Reads

Chondromyxoid fibroma of the sacrum: A case report and literature review.

Surg Neurol Int 2016 17;7(Suppl 13):S370-4. Epub 2016 May 17.

Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, CA, USA; Department of Neurosurgery, Kaiser Permanente Fontana Medical Center, Fontana, CA, USA.

Background: Chondromyxoid fibroma (CMF) is an extremely rare, benign cartilaginous tumor that makes up <0.5% of all bone tumors, typically presenting in the second or third decade of life. CMF of the sacrum is exceedingly rare, with only seven documented cases reported in the neurosurgical literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2152-7806.182547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879845PMC
June 2016
42 Reads

[EFFICACY OF BIOACTIVE GLASS AND ALLOGENIC BONE IN REPAIR OF BONE DEFECT AFTER BENIGN BONE TUMOR CURETTAGE].

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2016 Jun;30(6):675-679

Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Beijing, 100035, P.R.China.

Objective: To compare the healing process and clinical results of bioactive glass and allogenic bone in the repair of bone defects after benign bone tumor curettage.

Methods: Between November 2011 and December 2012, 20 patients with benign bone tumor received bioactive glass and allogenic bone for repair of bone defects after benign bone tumor curettage. There were 17 males and 3 females, aged 9-68 years (median, 18. Read More

View Article

Download full-text PDF

Source
http://www.rrsurg.com/article/10.7507/1002-1892.20160137
Publisher Site
http://dx.doi.org/10.7507/1002-1892.20160137DOI Listing
June 2016
5 Reads

Imaging features of chondromyxoid fibroma: report of 15 cases and literature review.

Br J Radiol 2016 Aug 26;89(1064):20160088. Epub 2016 May 26.

2 Department of Pathology, University Hospital Leuven and KU Leuven, Leuven, Belgium.

Objective:: Chondromyxoid fibroma (CMF) is a rare benign bony tumour. Our objectives are three-fold: first, comparing MRI, conventional radiography (CR) and CT characteristics of CMF; second, providing a literature review; and third, summarizing the role of imaging landmarks in the differential diagnosis with other bony lesions.

Methods:: 15 patients with histopathologically proven CMF were retrospectively included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20160088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124884PMC
August 2016
2 Reads

Fine needle aspiration cytology of chondroblastoma: A report of two cases with brief review of pitfalls.

J Cytol 2016 Jan-Mar;33(1):40-2

Department of Pathology, Adichunchanagiri Institute of Medical Sciences, Bengaluru, Karnataka, India.

Chondroblastoma is a rare, giant cell-rich, benign neoplasm of bone. Since the past few decades fine needle aspiration cytology (FNAC) has gained momentum in preoperative diagnosis of bone lesions. At cytology, other giant cell-rich tumors and tumorlike lesions such as aneurysmal bone cyst (ABC), giant cell tumor, and chondromyxoid fibroma fall under the differential diagnosis of chondroblastoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0970-9371.175514DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782403PMC
March 2016
5 Reads

Chondromyxoid fibroma of zygoma in an elderly patient: A rare presentation.

Ann Maxillofac Surg 2015 Jul-Dec;5(2):244-8

Department of Oral and Maxillofacial Surgery, Hospital Clínico Universidad de Chile, Chile.

Chondromyxoid fibroma (CF) is a benign bone tumor of cartilaginous origin and is considered the least common of cartilage-derived neoplasms. The lesion's most frequent location is in long bones, while involvement of craniofacial skeleton is extremely unusual. It generally appears in the second and third decade of life and most frequent in men. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2231-0746.175755DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772571PMC
March 2016
5 Reads

Rare case of sacral mass due to chondromyxoid fibroma.

BMJ Case Rep 2016 Mar 9;2016. Epub 2016 Mar 9.

Department of Orthopaedics and Traumatology, İstanbul Medeniyet University, Istanbul, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2015-214145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785414PMC
March 2016
2 Reads

Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant.

Diagn Pathol 2016 Mar 9;11:26. Epub 2016 Mar 9.

Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, 807-8555, Japan.

Background: Phosphaturic mesenchymal tumors (PMTs) are rare neoplasms that are often associated with tumor-induced osteomalacia (TIO) due to excessive serum levels of fibroblast growth factor 23 (FGF23). PMTs share overlapping histologic features with other types of tumors; thus, accurate pathological diagnosis may be challenging. We performed an immunohistochemical examination of FGF23 expression in PMTs and other types of tumors, together with pertinent molecular analyses. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13000-016-0477-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784377PMC
March 2016
7 Reads

Chondromyxoid Fibroma of the Skull Base and Calvarium: Surgical Management and Literature Review.

J Neurol Surg Rep 2016 Mar 4;77(1):e023-34. Epub 2016 Jan 4.

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States.

Chondromyxoid fibroma (CMF) is an exceedingly rare tumor that represents less than 1% of all primary bone neoplasms. Occurrence in the facial and cranial bones is extremely rare and frequently misdiagnosed. Case Reports We report two cases of CMF, one in the sphenoclival skull base and the other involving the parietal bone in two young female patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0035-1570033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726379PMC
March 2016
2 Reads

Acute cauda equina syndrome secondary to chondromyxoid fibroma of the lumbar spine.

Spine J 2016 Sep 12;16(9):e587-8. Epub 2016 Feb 12.

Department of Spine Surgery, The Second Xiangya Hospital of Central South University, No. 139, Middle of Renmin Rd, Changsha, Hunan410011, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.spinee.2016.02.002DOI Listing
September 2016
12 Reads
2.430 Impact Factor

External fixation reconstruction of the residual problems of benign bone tumours.

Strategies Trauma Limb Reconstr 2016 Apr 12;11(1):37-49. Epub 2016 Feb 12.

Orthopedic Department, Faculty of Medicine, Al-Azhar University Hospitals, Nasr City, Cairo, 11884, Egypt.

The mechanical features of and biologic response to using distraction osteogenesis with the circular external fixator are the unique aspects of Ilizarov's contribution that allows deformity correction and reconstruction of bone defects. We present a retrospective study of 20 patients who suffered from a variety of benign tumours for which external fixators (EF) were used to treat deformity, bone loss, and limb-length discrepancy. A total of 26 bony segments in twenty patients (10 males, 10 females; mean age 17 years; range 7-58 years) were treated with EF for residual problems from the tumour itself (primary treatment) in 8 patients and for complications related to the primary surgery (secondary treatment) in 12 patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11751-016-0244-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814386PMC
April 2016
9 Reads
1 Citation

Congenital bizarre parosteal osteochondromatous proliferation in unusual location and age: a case report.

Acta Orthop Traumatol Turc 2016 ;50(1):120-4

Baltalimanı Bone Diseases Training and Research Hospital, Department of Orthopaedic Oncology, İstanbul, Turkey.

Bizarre parosteal osteochondromatous proliferation (BPOP, also known as Nora's lesion) is a rare, benign, locally aggressive condition defined as osteochondromatous exostosis arising from the bony cortex. BPOP presents predominantly in the 2nd and 3rd decades of life, and commonly arises from the periosteum of metacarpals and metatarses, though rare locations have been reported, including the long bones, the maxillae, the bones of calvaria, and the sesamoids. The case of an osteochondromatous lesion in an infant with an intra-abdominal mass arising from the iliac wing, an atypical location of benign solitary lesions, is reported. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3944/AOTT.2016.13.0141DOI Listing
December 2016
25 Reads

Chondromyxoid fibroma of the pubic ramus: a case report and literature review.

Acta Orthop Traumatol Turc 2016 ;50(1):115-9

Ankara Oncology Training and Research Hospital, Department of Orthopaedics and Traumatology, Ankara, Turkey.

Chondromyxoid fibromas (CMF) are benign cartilaginous bone tumors which are found most frequently in the metaphyses of long bones. They comprise less than 1% of primary bone neoplasms. We report an interesting incidental case of a 43-year-old woman with a CMF of the left pubic ramus, presenting with complaints of gradual onset of left groin pain over a period of 2 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3944/AOTT.2016.14.0232DOI Listing
December 2016
14 Reads

Hydroxyapatite crystals as a bone graft substitute in benign lytic lesions of bone.

Indian J Orthop 2015 Nov-Dec;49(6):649-55

Department of Orthopaedics, G.S.V.M. Medical College, Kanpur, Uttar Pradesh, India.

Background: Bone grafts are required to fill a cavity created after curettage of benign lytic lesions of the bone. To avoid the problems associated at donor site with autologous bone graft, we require allograft or bone graft substitutes. We evaluated the healing of lytic lesions after hydroxyapatite (HA) grafting by serial radiographs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0019-5413.168767DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705732PMC
January 2016
1 Read

Cartilage-derived tumor in a prehispanic individual from La Gomera (Canary Islands).

Int J Paleopathol 2015 Dec 17;11:66-69. Epub 2015 Nov 17.

Department de Anatomía, Histología y Anatomía Patológica, Universidad de La Laguna, La Laguna, Tenerife, Canary Islands, Spain.

We present the case of a left tibia with an outgrowth at its distal metaphyseal/epiphyseal end, composed of cancellous bone, surrounding a destructive process that, on radiological examination, reaches the tibiotalar joint surface. The cancellous bone of the outgrowth is well preserved and is in continuity with intramedullary cancellous bone. The tibia belonged to a prehispanic adult individual, probably male, from La Gomera, in the Canary Archipelago. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpp.2015.09.005DOI Listing
December 2015
2 Reads

Surgical management of a giant sternal chondromyxoid fibroma: a case report.

J Cardiothorac Surg 2015 Nov 28;10:178. Epub 2015 Nov 28.

Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, #139 Renmin Middle Rd, Changsha, Hunan, 410011, P.R. China.

Background: A primary chondromyxoid fibroma (CMF) arising from sternum is quite uncommon tumor in thoracic surgery. Removal of giant sternal tumors requires extensive resection of the anterior chest wall, and results in deformity and paradoxical movement.

Case Presentation: A 40-year-old female presented a progressively enlarging mass of her anterior chest wall. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13019-015-0370-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663035PMC
November 2015
43 Reads